Skip to main content
OpenTrials
Completed

NCT Number: NCT01907204

Evaluation of Inhaled Treatment in Sinusitis

The purpose of this study is to determine whether inhaled corticosteroid (specially nebulized) could be a good alternative to oral corticosteroid and whether they are effective in the treatment of sinusitis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sinusitis Infections Nose Diseases Otorhinolaryngologic Diseases Paranasal Sinus Diseases Respiratory Tract Diseases Respiratory Tract Infections

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Nasal/Sinus polyps

Exclusion criteria

  • Previous sinus surgery
  • Age under 18y
  • Use of antibiotics

Treatment and study plan

methylprednisolone

Drug

Oral 32mg/8d-16mg/4d-8mg/4d

Budesonide

Drug

Budesonide by metered dose inhaler

Primary outcomes

  1. Sniffin' Sticks Test

    Time frame: Baseline and day 15

Secondary outcomes

  1. Specific quality of life questionnaire (Snot 20)

    Time frame: Baseline and day 15

  2. Retro Olfaction Test

    Time frame: Baseline and day 15

Sponsors and collaborators

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Other

Registry information

Official study title

Evaluation of Inhaled Corticosteroid Treatment in Sinusitis

Important dates

Study start
2013
Primary completion
2013
Study completion
2014
First posted
Jul 24, 2013
Registry last updated
Jan 27, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.